DWI-FLAIR mismatch versus perfusion-based selection for extended window thrombolysis in acute ischemic stroke: a meta-analysis of randomized controlled trials
Несоответствие DWI–FLAIR по сравнению с отбором на основе перфузии для тромболитической терапии в расширенном временном окне при остром ишемическом инсульте: метаанализ рандомизированных контролируемых исследований
2026-09-18
SCID: 54.1/3h85ybnw
Discuss with AI
DWI-FLAIR mismatchacute ischemic strokeextended-window thrombolysisperfusion-based selectionsymptomatic intracranial hemorrhage
Figures from the paper
Abstract (AI)
To compare efficacy and safety outcomes of DWI–FLAIR mismatch versus CT/MR perfusion-based selection for intravenous thrombolysis (IVT) in extended-window acute ischemic stroke (AIS), we performed a systematic review and meta-analysis of randomized controlled trials enrolling adults with acute ischemic stroke treated with imaging-selected IVT beyond 4.5 h from last known well or with unknown onset. Trials using DWI–FLAIR mismatch or CT/MR perfusion selection were included. Outcomes were excellent functional outcome, functional independence, symptomatic intracranial hemorrhage (sICH), parenchymal hematoma, major bleeding, and mortality. Random-effects pairwise meta-analysis and Bucher-type indirect comparison were performed. Eight randomized trials including 2,546 patients were analyzed. Compared with best medical treatment, IVT improved excellent functional outcome (mRS 0–1: RR 1.27, 95% CI 1.14–1.40) and functional independence (mRS 0–2: RR 1.15, 95% CI 1.07–1.23), but increased sICH (RR 5.21, 95% CI 2.25–12.04). In imaging-stratified analyses, functional outcome RRs favored IVT in both perfusion-based and DWI–FLAIR mismatch-selected trials, with wider confidence intervals in the DWI–FLAIR subgroup. Hemorrhagic risk was increased with intravenous thrombolysis in both imaging subgroups, but subgroup interaction testing and a Bucher-type indirect comparison did not detect a statistically significant between-paradigm difference; the indirect comparison re-expresses the subgroup contrast rather than adding independent evidence. In AIS patients not planned for routine endovascular therapy, imaging-selected IVT beyond 4.5 h was associated with improved functional outcomes but increased sICH risk. No definitive superiority or equivalence was established between imaging strategies; imaging choice should be guided by clinical context, time window, EVT eligibility, local workflow, and patient-level factors. This meta-analysis included eight randomized controlled trials involving 2,546 patients and compared imaging-selected intravenous thrombolysis (IVT) with best medical treatment (BMT) beyond 4.5 hours from last known well or with unknown onset. Overall pairwise meta-analysis showed improved excellent functional outcome (mRS 0–1; RR 1.27, 95% CI 1.14–1.40) and functional independence (mRS 0–2; RR 1.15, 95% CI 1.07–1.23) with IVT, with an increased risk of symptomatic intracranial hemorrhage (RR 5.21, 95% CI 2.25–12.04). Imaging-stratified analyses showed treatment effects favoring IVT in both perfusion-based and DWI–FLAIR mismatch-selected trials. Subgroup interaction tests and the Bucher-type indirect comparison did not demonstrate a statistically significant difference between imaging-selection strategies. Abbreviations: IVT, intravenous thrombolysis; BMT, best medical treatment; DWI, diffusion-weighted imaging; FLAIR, fluid-attenuated inversion recovery; mRS, modified Rankin Scale; RR, risk ratio; CI, confidence interval; sICH, symptomatic intracranial hemorrhage
Key Findings
1
Across eight randomized trials involving 2,546 patients, imaging-selected intravenous thrombolysis beyond 4.5 hours improved excellent functional outcome and functional independence versus medical treatment.
2
Functional outcomes favored thrombolysis in both perfusion-selected and DWI–FLAIR mismatch-selected trials, although confidence intervals were wider for the DWI–FLAIR subgroup.
3
Intravenous thrombolysis increased symptomatic intracranial hemorrhage risk compared with best medical treatment (RR 5.21, 95% CI 2.25–12.04).
4
Neither imaging strategy showed definitive superiority or equivalence; selection should consider clinical context, treatment timing, EVT eligibility, workflow, and patient-level factors.
5
No statistically significant difference in efficacy or hemorrhagic risk was demonstrated between perfusion-based and DWI–FLAIR mismatch selection strategies.
Research Object
adults with acute ischemic stroke receiving imaging-selected intravenous thrombolysis in the extended or unknown-onset window
Research Subject
the comparative efficacy and safety of DWI–FLAIR mismatch versus CT/MR perfusion-based selection for extended-window intravenous thrombolysis, including functional and hemorrhagic outcomes
Publication Details
Publication Date
2026-09-18
Journal
Publisher
ISSN
Cited by
0
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai6
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews2021
RoB 2: a revised tool for assessing risk of bias in randomised trials2019
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association2019
2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association2026
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy2024
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection2024